Akzo Nobel Valuation

Is AKZO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AKZO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AKZO (€55.6) is trading below our estimate of fair value (€141.95)

Significantly Below Fair Value: AKZO is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for AKZO?

Key metric: As AKZO is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AKZO. This is calculated by dividing AKZO's market cap by their current earnings.
What is AKZO's PE Ratio?
PE Ratio16.9x
Earnings€565.00m
Market Cap€9.54b

Price to Earnings Ratio vs Peers

How does AKZO's PE Ratio compare to its peers?

The above table shows the PE ratio for AKZO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average26.7x
WIE Wienerberger
42.3x47.0%€2.9b
603260 Hoshine Silicon Industry
36.6x37.8%CN¥70.5b
6988 Nitto Denko
13.2x2.1%JP¥1.8t
002001 Zhejiang NHU
14.7x10.3%CN¥66.5b
AKZO Akzo Nobel
16.9x12.1%€9.5b

Price-To-Earnings vs Peers: AKZO is good value based on its Price-To-Earnings Ratio (16.9x) compared to the peer average (26.7x).


Price to Earnings Ratio vs Industry

How does AKZO's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
AKZO 16.9xIndustry Avg. 16.9xNo. of Companies12PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: AKZO is expensive based on its Price-To-Earnings Ratio (16.9x) compared to the European Chemicals industry average (16.9x).


Price to Earnings Ratio vs Fair Ratio

What is AKZO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AKZO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.9x
Fair PE Ratio21.5x

Price-To-Earnings vs Fair Ratio: AKZO is good value based on its Price-To-Earnings Ratio (16.9x) compared to the estimated Fair Price-To-Earnings Ratio (21.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AKZO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€55.60
€73.47
+32.1%
10.7%€90.00€57.00n/a19
Dec ’25€55.00
€73.53
+33.7%
10.5%€90.00€58.00n/a19
Nov ’25€59.12
€73.47
+24.3%
10.5%€91.00€58.00n/a19
Oct ’25€63.16
€73.53
+16.4%
12.6%€91.00€54.00n/a19
Sep ’25€57.76
€72.89
+26.2%
13.6%€91.00€53.00n/a18
Aug ’25€56.60
€73.06
+29.1%
13.3%€91.00€53.00n/a18
Jul ’25€56.24
€75.94
+35.0%
13.4%€94.00€53.00n/a18
Jun ’25€63.84
€78.28
+22.6%
9.7%€94.00€65.00n/a18
May ’25€62.14
€78.39
+26.1%
9.8%€94.00€65.00n/a18
Apr ’25€70.14
€78.64
+12.1%
10.7%€96.00€63.00n/a18
Mar ’25€67.64
€79.08
+16.9%
9.7%€96.00€65.00n/a18
Feb ’25€70.82
€79.61
+12.4%
10.9%€96.00€65.00n/a19
Jan ’25€75.00
€79.05
+5.4%
13.2%€100.00€60.00n/a19
Dec ’24€70.72
€79.42
+12.3%
13.2%€100.00€60.00€55.0019
Nov ’24€63.38
€80.89
+27.6%
12.0%€100.00€60.00€59.1219
Oct ’24€67.84
€83.29
+22.8%
8.6%€94.00€68.50€63.1619
Sep ’24€75.24
€82.82
+10.1%
10.1%€100.00€68.50€57.7619
Aug ’24€78.20
€82.61
+5.6%
10.1%€100.00€68.50€56.6019
Jul ’24€72.90
€82.21
+12.8%
11.0%€100.00€63.00€56.2419
Jun ’24€70.32
€80.33
+14.2%
15.6%€100.00€42.52€63.8420
May ’24€75.38
€79.20
+5.1%
15.5%€100.00€42.52€62.1420
Apr ’24n/a
€76.60
0%
16.5%€100.00€42.52€70.1420
Mar ’24n/a
€76.68
0%
16.4%€100.00€42.52€67.6420
Feb ’24€68.26
€75.58
+10.7%
16.6%€100.00€42.52€70.8220
Jan ’24€63.36
€78.79
+24.3%
18.3%€110.00€42.52€75.0021
Dec ’23€67.06
€78.79
+17.5%
18.4%€110.00€42.52€70.7221

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:29
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Akzo Nobel N.V. is covered by 58 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mutlu GundoganABN AMRO Bank N.V.
Martin SchneeAlphaValue
Colin IsaacAtlantic Equities LLP